Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRT5005 in adults with cystic fibrosis
NCT03375047Phase 2Completed
- Sponsor
- Sanofi
- Start
- May 2018
- Primary completion
- Mar 2022
- Countries
- 1
01
Overview
A Phase 2 trial of MRT5005 in cystic fibrosis (CF), sponsored by Sanofi. Started May 2018; status: completed.
02
Drugs
MRT5005
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT03375047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03375047.